05.09.2016 Views

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ERS International Congress 2016<br />

DETAILED PROGRAMME<br />

MONDAY 05 SEPTEMBER, 2016<br />

Aims : The session will provide an updated overview of the main achievements of the basic research on pleural empyema that are relevant<br />

for clinicians. In particular, the key benefits of the modern therapeutic procedures for pleural empyema, which are largely based on videoassisted<br />

technology (VAT), will be described. The take-home message will be that depending on the disease stage, optimal engagement<br />

between pulmonologists and surgeons is essential. The main pitfalls that relate to this disease will also be presented to facilitate<br />

recognition of the underlying diseases, as those diseases may not always be obvious at first.<br />

Track(s) : Infection Intensive care<br />

Tag(s) : Translational<br />

Target audience : Physiotherapist, Respiratory physician, Resident, Pulmonologist, Thoracic surgeon<br />

Chairs : Danail Petrov (Sofia, Bulgaria), Hans-Beat Ris (LAUSANNE, Switzerland)<br />

08:30<br />

09:00<br />

09:30<br />

New insights into an old disease<br />

Gernot G.U. Rohde (Maastricht, Netherlands)<br />

How to prevent progression to stage III disease<br />

Philippe Astoul (Marseille, France)<br />

The changing spectrum of surgical solutions: video-assisted thoracic surgery (VATS), robotics, and<br />

open surgery<br />

Didier Lardinois (Basel, Switzerland)<br />

1755<br />

1756<br />

1757<br />

10:00<br />

Major pitfalls in pleural empyema: what about the underlying disease?<br />

Dragan R. Subotic (Belgrade, Republic of Serbia)<br />

Platinum Room 1+2 Session 326 08:30 - 10:30<br />

Symposium: Diagnosing primary ciliary dyskinesia (PCD) in a molecular age<br />

Aims : The aims of this session are to explain the importance of an accurate diagnosis from the patients’ perspective; describe the barriers<br />

to obtaining a diagnosis for this rare ‘orphan’ lung disease; present data from an international survey of >300 patients conducted as part of<br />

the PCD task force; describe the clinical features that should prompt referral for diagnostic testing; discuss the disparity of diagnostic<br />

services in Europe; explain the pathophysiology and genetic basis of PCD; and present the recommendations of the ERS PCD task force<br />

"Diagnosis of primary ciliary dyskinesia (PCD) in a molecular age: A practice guideline for diagnosing patients with PCD."<br />

Track(s) : Paediatric<br />

Tag(s) : Clinical<br />

Target audience : Allied health professional, Clinician, Fellow, General practitioner, Junior member, Lung function technician,<br />

Neonatologist, Nurse, Otolaryngologist, Paediatrician, Pathologist, Patient, Physiotherapist, Pulmonologist, Researcher, Resident,<br />

Respiratory physician, Respiratory therapist, Scientist, Trainee<br />

Chairs : Andrew Bush (LONDON, United Kingdom), Angelo Barbato (Padova, PD, Italy)<br />

1758<br />

08:30<br />

09:00<br />

09:30<br />

Patients’ perspectives on diagnostic testing<br />

Fiona Copeland (Milton Keynes, United Kingdom)<br />

Barriers and solutions to accurate diagnoses<br />

Claudia Kuehni (Bern, Switzerland)<br />

Genetic mechanisms of PCD<br />

Heymut Omran (Münster, Germany)<br />

1759<br />

1760<br />

1761<br />

10:00<br />

ERS PCD task force recommendations for diagnostic testing<br />

Jane Lucas (Southampton, United Kingdom)<br />

Platinum Room 3+4 Session 327 08:30 - 10:30<br />

Oral Presentation: New and old therapies for chronic lung diseases<br />

Chairs : Philippe Camus (DIJON, France), Alfredo Chetta (PARMA (PR), Italy)<br />

1762<br />

OA1763<br />

OA1766<br />

LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with<br />

inhaled corticosteroids (ICS): An across-trials model-based approach<br />

Neil C. Barnes (London, United Kingdom), Salman H. Siddiqui, Ian Pavord, Neil C. Barnes, Sally Lettis, Alessandro<br />

Guasconi, Stefano Petruzzelli<br />

Protective effects of vitamin D supplementation against acute respiratory infection are greatest in those with the<br />

lowest baseline vitamin D status<br />

Adrian R Martineau (London, United Kingdom), Adrian R. Martineau, David A. Jolliffe, Richard L. Hooper, Lauren<br />

Greenberg, John F. Aloia, Peter Bergman, Gal Dubnov-Raz, Susanna Esposito, Davaasambuu Ganmaa, Emma C. Goodall,<br />

Cameron Grant, Christopher J. Griffiths, Wim Janssens, Ilkka Laaksi, Semira Manaseki-Holland, David Murdoch, Rachel E.<br />

Neale, Judy R. Rees, Steve Simpson, Iwona Stelmach, Geeta Trilok Kumar, Mitsuyoshi Urashima, Carlos A. Camargo<br />

124 26.08.2016

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!